Utah Medical Products: Q3 GAAP EPS of $0.87 and revenue of $8.62M
FROM THE WIRE · SEEKINGALPHA.COM
* Utah Medical Products press release [https://seekingalpha.com/pr/20696492-utmd-reports-financial-performance-for-third-calendar-quarter-and-nine-months-2026] (UTMD [https://seekingalpha.com/symbol/UTMD]): Q3 GAAP EPS of $0.87. * Revenue of $8.62M. * UTMD paid $987…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishQuarterly results with the stock up 7.3% over the quarter, relevant for UTMD shares.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01UTMD closed Q3 2026 at $74.05, up 7.3% over the quarter.
- 02Dividends paid in Q3 2026 were $0.310 per share.
- 03Nine-month 2026 dividends equalled 37% of net income.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets